APEX2 is Required for Efficient TERT Expression in Human Embryonic Stem Cells

Study Background and Research Question

Maintenance of telomere length is fundamental to the self-renewal capacity of human embryonic stem cells (hESCs) and is tightly regulated by the telomerase complex. The catalytic subunit of telomerase, TERT (telomerase reverse transcriptase), is crucial for preventing telomere shortening and is primarily expressed in stem cells and cancer cells. Despite its importance, the transcriptional regulation of TERT in human cells remains incompletely understood, partly due to the low endogenous expression levels of TERT and the lack of suitable animal models that recapitulate human TERT regulation (source: paper).

Recent research has implicated DNA repair proteins in the modulation of gene expression, particularly in response to DNA damage at repetitive genomic elements. The current study investigates whether apurinic/apyrimidinic endodeoxyribonuclease 2 (APEX2), a DNA repair enzyme primarily known for its role in base excision repair, has a previously unrecognized function in regulating TERT expression in hESCs.

Key Innovation from the Reference Study

The central innovation of this work lies in identifying APEX2 as a critical determinant of TERT gene transcription in human embryonic stem cells and melanoma cells. While APEX1, a close paralog, has established roles in gene regulation via transcription factor control, this is the first evidence that APEX2 facilitates efficient transcription of TERT and other genes associated with repetitive DNA elements (source: paper).

This research uncovers a mechanistic link between DNA repair at repetitive elements—specifically mammalian-wide interspersed repeats (MIRs) and Alu elements—and the maintenance of telomerase activity, expanding our understanding of the interplay between genome stability and stem cell function.

Methods and Experimental Design Insights

The investigators utilized a combination of genetic and genomic approaches to dissect the role of APEX2 in TERT regulation:

• RNA Interference: APEX2 was specifically knocked down in hESCs and a melanoma cell line, while APEX1 was depleted as a control.
• Telomerase Activity Assays: Quantitative assays measured telomerase enzyme activity in response to APEX2 depletion.
• RNA Sequencing (RNA-seq): Genome-wide transcriptional profiling post-APEX2 knockdown identified differentially expressed genes and enrichment of affected genes in specific DNA repeat families.
• Chromatin Immunoprecipitation (ChIP): APEX2 binding sites were mapped across the TERT locus and genome-wide, focusing on enrichment at MIR and Alu elements.

Through this multi-pronged approach, the study robustly connects APEX2 function to TERT expression and highlights the importance of repetitive DNA elements as regulatory hubs in stem cells.

Protocol Parameters

• RNA interference (APEX2 knockdown) | 70–90% reduction in target mRNA | hESCs, melanoma cells | Achieves significant depletion to assess functional impact on TERT and global gene expression | paper
• Telomerase activity assay | Relative activity normalized to control | hESCs, melanoma cells | Detects functional consequences of APEX2 depletion on telomerase | paper
• RNA-seq (post-knockdown) | ~30–50 million reads/sample | hESCs | Sufficient depth for transcriptome-wide differential expression analysis | paper
• ChIP-qPCR (APEX2 enrichment) | Fold-enrichment at MIRs vs. promoter | hESCs | Determines APEX2 binding preference within TERT locus | paper

Core Findings and Why They Matter

The study's major findings are as follows:

• APEX2, but not APEX1, is required for efficient TERT expression: Knockdown of APEX2 in hESCs and melanoma cells significantly reduced TERT mRNA and telomerase activity, while APEX1 depletion had no such effect (source: paper).
• APEX2 influences a subset of genes linked to repetitive DNA elements: RNA-seq revealed that APEX2-dependent genes are enriched for those containing MIR and Alu elements, suggesting a broader regulatory role for APEX2 at repetitive DNA.
• APEX2 preferentially binds to MIR sequences within TERT intron 2: ChIP experiments demonstrated the highest APEX2 occupancy at MIRs in TERT intron 2, with limited binding at the TERT proximal promoter, indicating that regulatory control is exerted via intronic repetitive DNA rather than classic promoter elements.
• Functional link to genome stability: Since MIRs and Alu elements are frequent sites of DNA damage, APEX2 appears to couple DNA repair to gene expression, possibly by resolving lesions that would otherwise impede transcription of critical genes like TERT.

These results have implications for understanding the molecular basis of stem cell maintenance, aging, and cancer, where aberrant TERT regulation and telomere dysfunction play central roles. The discovery that DNA repair at specific repetitive elements modulates gene expression may inform new strategies for controlling telomerase activity in therapeutic contexts.

Comparison with Existing Internal Articles

Several recent internal articles discuss the use of MEK inhibitors such as PD0325901 in the context of RAS/RAF/MEK/ERK signaling pathway inhibition and stem cell biology:

• Translational Frontiers in Oncology positions PD0325901 as a precision tool for modulating the RAS/RAF/MEK/ERK pathway, with emerging evidence linking pathway activity to regulation of telomerase, cell cycle arrest, and apoptosis induction in cancer cells. This aligns with the current paper's focus on upstream DNA repair and transcriptional regulation of TERT as a convergence point for cellular immortality and oncogenesis.
• Selective MEK Inhibitor for Cancer Research Workflows specifically highlights the utility of PD0325901 for inducing apoptosis and G1/S cell cycle arrest, both of which may intersect functionally with telomerase regulation and DNA repair dependencies in cancer stem-like cells.
• While the present study does not directly assess MEK inhibition, the regulatory crosstalk between DNA repair, telomerase, and cell fate aligns with the mechanistic themes explored in these articles, underscoring the interconnectedness of DNA repair, signaling, and transcriptional control in stem cell and cancer biology.

Limitations and Transferability

Several limitations should be considered when interpreting these findings:

• Model specificity: Results are derived from human embryonic stem cells and a melanoma cell line; whether similar mechanisms operate in adult somatic stem cells or other cancer types remains to be determined (source: paper).
• Mechanism of action: While APEX2 binding at MIRs is demonstrated, the precise molecular events linking DNA repair at repetitive elements to TERT transcriptional activation require further elucidation.
• In vivo relevance: The study focuses on cell-based models; validation in primary tissues and animal models is necessary to establish physiological and therapeutic significance.

Nevertheless, the findings provide a valuable framework for future investigation of DNA repair enzymes as regulators of gene expression and as potential therapeutic targets in aging and cancer.

Research Support Resources

To experimentally dissect the interplay between DNA repair, telomerase regulation, and cell signaling, researchers may benefit from tools that enable precise pathway inhibition and cell fate control. For example, the selective MEK inhibitor PD0325901 (SKU A3013, APExBIO) can be used to modulate the RAS/RAF/MEK/ERK pathway, which is frequently hyperactivated in cancer models and has been implicated in the control of cell proliferation, apoptosis, and telomerase activity (workflow_recommendation). PD0325901 facilitates dose- and time-dependent G1/S cell cycle arrest and apoptosis induction in cancer cells, supporting studies of pathway crosstalk and gene expression regulation, including potential intersections with TERT and DNA repair mechanisms. This compound is intended for research use only.